Media Coverage Year 2022 2021 2020 2019 2018 2017 2016 Search PipelineReview Senhwa Biosciences Announces Dose Escalation Initiation of the Phase I Trial of Pidnarulex as a Treatment for Advanced Hematological Malignancies Aug 26 2021 OncLive Silmitasertib Gets Fast Track Status for Recurrent Sonic Hedgehog–Driven Medulloblastoma Aug 26 2021 Market Watch Senhwa’s Silmitasertib Receives US FDA Fast Track Designation for the Treatment of Recurrent Sonic Hedgehog Driven Medulloblastoma Aug 18 2021 Yahoo Finance Senhwa Completes Enrollment of a Phase 2 Investigator Initiated Trial of Silmitasertib as Novel Oral Drug for COVID-19 Aug 16 2021 PR Newswire Senhwa Signs Agreement with Taiwan’s CDE for COVID-19 Program Guiding Development of Silmitasertib Aug 14 2021 Focus Taiwan CORONAVIRUS/Taiwan COVID-19 drug gets positive review, clinical trials to advance Mar 15 2021 PR Newswire Senhwa Announces Acceptance of Early Positive COVID-19 Phase II Study Abstract for Presentation at the ISIRV-WHO Conference Sep 27 2021 BEING WELL Is Silmitasertib the Covid-19 Treatment Breakthrough We’ve Been Waiting for? Sep 14 2020 1 2 3 4